INXMED
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equipped with global-level top-notch know-how and efficient execution capabilities.
INXMED
Social Links:
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.en.inxmed.com
Total Employee:
11+
Status:
Active
Contact:
+0086-21-50630108
Email Addresses:
[email protected]
Total Funding:
94 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Euro Microsoft Exchange Online Office 365 Mail IPv6 Pound Sterling
Similar Organizations
Alebund Pharmaceuticals
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
AUM Biosciences
AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Nectin Therapeutics
Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Visen Pharmaceuticals
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
SPD Silicon Valley Bank (SSVB)
SPD Silicon Valley Bank (SSVB) investment in Debt Financing - InxMed
Hyfinity Investments
Hyfinity Investments investment in Series B - InxMed
Ennovation Ventures
Ennovation Ventures investment in Series B - InxMed
AIHC Capital
AIHC Capital investment in Series B - InxMed
CS Capital
CS Capital investment in Series B - InxMed
HosenCare Brothers
HosenCare Brothers investment in Series B - InxMed
Ennovation Ventures
Ennovation Ventures investment in Series A - InxMed
China Growth Capital | CGC
China Growth Capital | CGC investment in Series A - InxMed
InnoMed Capital
InnoMed Capital investment in Series A - InxMed
Grand Yangtze Capital
Grand Yangtze Capital investment in Series A - InxMed
Official Site Inspections
http://www.en.inxmed.com
- Host name: server-99-84-188-57.iad89.r.cloudfront.net
- IP address: 99.84.188.57
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "InxMed"
Overview_InxMed-Leading Innovations Targeting Tumor Defense
InxMed is a clinical-stage biotech company established in the end of 2018. The company dedicates on developing innovative therapies targeting stroma microenvironment and solid …See details»
InxMed - Crunchbase Company Profile & Funding
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. …See details»
About_InxMed-Leading Innovations Targeting Tumor Defense
About-InxMed-Leading Innovations Targeting Tumor DefenseInxMed is a clinical-stage biotech company established in 2018. The company is dedicated to developing innovative therapies …See details»
InxMed (Nanjing) Co., Ltd. - life-sciences-europe.com
Mar 1, 2020 InxMed is a clinical-stage biotech company established in the end of 2018. The company dedicates on developing innovative therapies targeting stroma microenvironment …See details»
InxMed - VentureRadar
Established in 2018, InxMed strives to be a China-based global new drug development engine dedicated to the development of innovative drugs. We are building up a differentiated pipeline …See details»
InxMed Company Profile - Office Locations, Competitors, Revenue …
InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines. It builds up a differentiated drug pipeline with the potential of intrinsic synergy to …See details»
InxMed 2025 Company Profile: Valuation, Funding
InxMed General Information Description. Developer of cancer therapeutics designed to treat cancer. The company currently has pharmaceuticals targeting pancreatic, ovarian, gastric and other forms of cancer, enabling healthcare …See details»
Inxmed - Company Profile - Tracxn
Corporates and Startups. Corp Dev and M&A Teams Corporate Innovation Startup Founders Sales Team. EcosystemSee details»
Our Science_InxMed-Leading Innovations Targeting Tumor Defense
Our Science-InxMed-Leading Innovations Targeting Tumor DefenseInxMed is a clinical-stage biotech company established in 2018. The company is dedicated to developing innovative …See details»
厚新健投 - InxMed (Nanjing) Co., Ltd.
CN EN InxMed (Nanjing) Co., Ltd. InxMed is a clinical-stage biotech firm founded at the end of 2018. The company is committed to developing novel therapies that target the stroma …See details»
InxMed Co, Ltd - VentureRadar
"InxMed is a clinical-stage biotech company established in the end of 2018. The company dedicates on developing innovative therapies targeting stroma microenvironment and solid …See details»
InxMed - Contacts, Employees, Board Members, Advisors
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact. New. Resources. Advanced Search. Start Free Trial . Talk …See details»
InxMed Company Information - Funding, Investors, and More
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
InxMed Raised $15 million in Series B+ Financing to Advance …
May 9, 2022 InxMed is a clinical-stage biotech company established in the end of 2018. The company dedicates on developing innovative therapies targeting stroma microenvironment …See details»
InxMed Raised $50 million in Series B Financing to Advance …
NANJING, China, March 3, 2022 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and …See details»
InxMed Raised $15 million in Series B+ Financing to Advance
NANJING, China, May 8, 2022 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and …See details»
History_InxMed-Leading Innovations Targeting Tumor Defense
History-InxMed-Leading Innovations Targeting Tumor DefenseInxMed is a clinical-stage biotech company established in 2018. The company is dedicated to developing innovative therapies …See details»
Patient-reported outcomes from the MIRASOL trial evaluating ...
1 day ago MIRV did not seem to impair or improve patient quality of life compared with investigator's choice of chemotherapy. The similar quality-of-life outcomes in the two treatment …See details»
Join us_InxMed-Leading Innovations Targeting Tumor Defense
Join us-InxMed-Leading Innovations Targeting Tumor DefenseInxMed is a clinical-stage biotech company established in 2018. The company is dedicated to developing innovative therapies …See details»
Partnerships_InxMed-Leading Innovations Targeting Tumor Defense
Partnerships-InxMed-Leading Innovations Targeting Tumor DefenseInxMed is a clinical-stage biotech company established in 2018. The company is dedicated to developing innovative …See details»